Merit Financial Group’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.35K Sell
1,264
-412
-25% -$3.05K ﹤0.01% 1692
2025
Q1
$14.4K Buy
+1,676
New +$14.4K ﹤0.01% 1391